Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,109,551 papers from all fields of science
Search
Sign In
Create Free Account
eliglustat 84 MG Oral Capsule [Cerdelga]
Known as:
Cerdelga 84 MG (as eliglustat tartrate 100 MG) Oral Capsule
, Cerdelga 84 MG Oral Capsule
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
11 relations
Indigo Carmine
Lactose Monohydrate
Mica
Oral Capsule
Expand
Broader (1)
eliglustat 84 MG Oral Capsule
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
European Commission Grants Marketing Authorization for Cerdelga® (eliglustat), Genzyme’s Oral Therapy for Gaucher Disease Type 1
2015
Corpus ID: 53465856
Paris January 22, 2015 Sanofi and its subsidiary Genzyme announced today that the European Commission (EC) has granted marketing…
Expand
Review
2015
Review
2015
Eliglustat: A Review in Gaucher Disease Type 1
L. Scott
Drugs
2015
Corpus ID: 22395026
Oral eliglustat (Cerdelga®) is approved in several countries for the long-term treatment of adults with Gaucher disease type 1…
Expand
Review
2014
Review
2014
Eliglustat: First Global Approval
R. Poole
Drugs
2014
Corpus ID: 24320552
Eliglustat [Cerdelga™ (US, EU)], a small-molecule oral glucosylceramide analogue that inhibits the enzyme glucosylceramide…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE